AgeneBio

Business Services · Maryland, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

1340 Smith Ave Ste 200, Baltimore, Maryl...

Phone Number

(410) 779-1260

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About AgeneBio

AgeneBio is dedicated to discovering and developing innovative therapeutics aimed at preserving brain function for patients at risk of neurological and psychiatric conditions. Their primary focus is on a late-stage clinical program that seeks to prevent Alzheimer's dementia. The company also addresses conditions such as mild cognitive impairment due to Alzheimer's disease, autism, and schizophrenia. AgeneBio's mission is to enhance the lives of patients, their families, and society through their therapeutic advancements.Explore more
AgeneBio's Social MediaPopular Searchesagenebio IncAgeneBioSIC Code 87,873NAICS Code 54,541Show more

AgeneBio Org Chart

MG
United States flag for contact location.

Founder & Chief Executive Officer

PhoneEmail
KP
United States flag for contact location.

Director of CM & C

PhoneEmail
SF
United States flag for contact location.

Director, Business Operations

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is AgeneBio your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to AgeneBio

Compare insights from companies similar to AgeneBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

AgeneBio

<$5M
1-10
Private
$17.8M
2008
<$5M
1-10
Private
-
2002
SL
Shane LiResearch Associate
<$5M
11-50
Private
$13.1M
2010
N/A
<$5M
11-50
Private
-
-
DH
Dana HasselbacherFounder & Creative Director
<$5M
1-10
Public
<$5M
2011
N/A
<$5M
1-10
Private
-
2012
AM
Alain MorèreProfessor, Co-Founder and Scientific Advisor of NanoMedSyn
<$5M
1-10
Private
-
2003
AF
Amie FranklinSenior VP, Research & Development
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

AgeneBio is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

AgeneBio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AgeneBio.

AgeneBio financials insights

Gather financial insights about AgeneBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2010

Debt

$3.7M

2013

Other Financing Round

$1M

Other Financing Round

$1M

2014

Private Equity

$4.1M

2015

Grant

$7.5M

2019

Grant

$500K

See All AgeneBio's Financials Insights

AgeneBio Tech Stack

A closer look at the technologies used by AgeneBio

Top Business Services Companies

Frequently Asked Questions Regarding AgeneBio

What is AgeneBio's official website?
AgeneBio's official website is www.agenebio.com
What is AgeneBio's Revenue?
AgeneBio's revenue is <$5 Million
What is AgeneBio's SIC code?
AgeneBio's SIC: 87,873
What is AgeneBio's NAICS code?
AgeneBio's NAICS: 54,541
How many employees does AgeneBio have?
AgeneBio has 1-10 employees
What industry does AgeneBio belong to?
AgeneBio is in the industry of: Business Services, Research & Development
What is AgeneBio competition?
AgeneBio top competitors include: Biomarker Pharmaceuticals, NanoMedSyn, Atentiv, PluroGen Therapeutics
What technology does AgeneBio use?
Some of the popular technologies that AgeneBio uses are: WordPress.org, AppRiver, Google Font API, Microsoft 365
How do I contact AgeneBio?
AgeneBio contact info: Phone number: (410) 779-1260 Website: www.agenebio.com
What does AgeneBio do?

AgeneBio is dedicated to discovering and developing innovative therapeutics aimed at preserving brain function for patients at risk of neurological and psychiatric conditions. Their primary focus is on a late-stage clinical program that seeks to prevent Alzheimer's dementia. The company also addresses conditions such as mild cognitive impairment du... e to Alzheimer's disease, autism, and schizophrenia. AgeneBio's mission is to enhance the lives of patients, their families, and society through their therapeutic advancements.Read More

What are AgeneBio social media links?
AgeneBio Linkedin page AgeneBio Twitter page
Who invested in AgeneBio?
AgeneBio has 6 investors including The Alzheimer's Drug Discovery Foundation and National Institutes of Health.
Is AgeneBio a public company?
AgeneBio is private company therefore does not currently have an official ticker symbol
See more information about AgeneBio

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.